A COMPARATIVE ANALYSIS OF PREVALENCE OF PSYCHIATRIC MORBIDITIES IN METABOLIC SYNDROME PATIENTS Article Swipe
YOU?
·
· 2017
· Open Access
·
· DOI: https://doi.org/10.14260/jemds/2017/972
· OA: W2753705696
BACKGROUNDMetabolic syndrome is by definition a multisystem disorder.Metabolic syndrome, Syndrome X and Insulin resistance syndrome are all terms coined to describe the recognised clustering of metabolic and cardiovascular abnormalities including abnormalities of glucose homeostasis (insulin resistance, glucose intolerance or diabetes mellitus), obesity, hypertension and dyslipidaemia.The aim of this study is to compare prevalence of psychiatric morbidities like depression and anxiety in Metabolic syndrome patients. MATERIALS AND METHODSThis is a case-control study done in 50 patients of metabolic syndrome and 50 controls in a tertiary care setting in urban region in Tamilnadu from 2015 -2016 for a period of 6 months.The Metabolic Syndrome is screened using standardised clinical and laboratory parameters and National Cholesterol Education Program-Adult Treatment Panel 3 (NCEP-ATP 3) and anxiety and depression were measured in the cases and control using Hamilton Rating Scale for Anxiety (HAM-A) and Beck Depression Inventory (BDI). RESULTSMetabolic Syndrome was associated with Depression and Anxiety and the participants with Metabolic Syndrome had high score of Depression (40%) and Anxiety (14%) than control group score for Depression (34%) and Anxiety (10%), and there is a significant relationship of Depression and Anxiety in Metabolic syndrome patient than control group.The 'P' value for Depression is 0.008 and the 'P' value for Anxiety is 0.012. CONCLUSIONThe study shows an association between Metabolic Syndrome and Depression and Anxiety in heterogeneous sample.The presence of Depression and Anxiety in individuals with Metabolic Syndrome has implications for clinical management.
